18392

0

MONOPHARMA

img img img img
No Data Available

MONO PHARMACARE LIMITED Share Price Update

MONO PHARMACARE LIMITED performance

Today’s low Today’s high
₹ 11.90 ₹ 11.90
₹ 11.90
52 week low 52 week high
₹ 9.45 ₹ 28.25
₹ 11.90
Open Price ₹ 11.90
Prev. Close ₹ 12.50
Volume (Shares) 4000.00
Total traded value ₹ .47
Upper Circuit ₹ 13.10
Lower Circuit ₹ 11.90
info

MONO PHARMACARE LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text

MONO PHARMACARE LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 82.64
Operating Expense 81.39
Net Profit 3.09
Net Profit Margin (%) 3.73
Earnings Per Share (EPS) 1.75
EBITDA 5.09
Effective Tax Rate (%) 18.03
Particulars MAR 2024 (Values in Cr)
Revenue 70.72
Operating Expense 69.55
Net Profit 2.44
Net Profit Margin (%) 3.45
Earnings Per Share (EPS) 1.59
EBITDA 4.15
Effective Tax Rate (%) 14.33
Particulars MAR 2023 (Values in Cr)
Revenue 45.40
Operating Expense 44.08
Net Profit 1.23
Net Profit Margin (%) 2.70
Earnings Per Share (EPS) 1.80
EBITDA 2.58
Effective Tax Rate (%) 21.01
Particulars MAR 2025 (Values in Cr)
Book Value / Share 17.66
ROE % 10.49
ROCE % 11.01
Total Debt to Total Equity 1.60
EBITDA Margin 5.12
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.91
ROE % 11.86
ROCE % 10.22
Total Debt to Total Equity 1.97
EBITDA Margin 5.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.82
ROE % 5.23
ROCE % 3.16
Total Debt to Total Equity 3.03
EBITDA Margin 6.48
Particulars MAR 2025 (Values in Cr)
Book Value / Share 17.66
ROE % 10.42
ROCE % 10.39
Total Debt to Total Equity 0.62
EBITDA Margin 6.17
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.91
ROE % 11.76
ROCE % 12.06
Total Debt to Total Equity 0.62
EBITDA Margin 5.87
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.83
ROE % 4.03
ROCE % 4.01
Total Debt to Total Equity 0.93
EBITDA Margin 7.69
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.69
Total Assets 110.05
Total Liabilities 110.05
Total Equity 31.23
Share Outstanding 1
Price to Book Ratio 1.31
Return on Assets (%) 2.80
Return on Capital (%) 3.64
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.36
Total Assets 81.11
Total Liabilities 81.11
Total Equity 28.12
Share Outstanding 1
Price to Book Ratio 2.77
Return on Assets (%) 3.01
Return on Capital (%) 3.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 62.60
Total Liabilities 62.60
Total Equity 13.39
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 1.11
Return on Capital (%) 1.3
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 66.06
Total Liabilities 66.06
Total Equity 31.19
Share Outstanding 1
Price to Book Ratio 1.31
Return on Assets (%) 4.67
Return on Capital (%) 5.63
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 45.40
Total Liabilities 45.40
Total Equity 28.10
Share Outstanding 1
Price to Book Ratio 2.77
Return on Assets (%) 5.37
Return on Capital (%) 5.9
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 29.06
Total Liabilities 29.06
Total Equity 13.39
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 1.86
Return on Capital (%) 2.09
Particulars MAR 2025 (Values in Cr)
Net Income 4.46
Cash from Operations -2.91
Cash from Investing -0.22
Cash from Financing 4.86
Net change in Cash 0.33
Free Cash Flow -2.68
Particulars MAR 2024 (Values in Cr)
Net Income 3.22
Cash from Operations -8.04
Cash from Investing 0.39
Cash from Financing 8.31
Net change in Cash -0.05
Free Cash Flow -7.86
Particulars MAR 2023 (Values in Cr)
Net Income 0.92
Cash from Operations -27.75
Cash from Investing -1.43
Cash from Financing 29.60
Net change in Cash 0.41
Free Cash Flow -26.89
Particulars MAR 2025 (Values in Cr)
Net Income 3.77
Cash from Operations -0.01
Cash from Investing -7.42
Cash from Financing 8.01
Net change in Cash -0.13
Free Cash Flow 0.16
Particulars MAR 2024 (Values in Cr)
Net Income 2.85
Cash from Operations -9.94
Cash from Investing -1.65
Cash from Financing 11.99
Net change in Cash 0.02
Free Cash Flow -9.91
Particulars MAR 2023 (Values in Cr)
Net Income 0.66
Cash from Operations -13.31
Cash from Investing -2.17
Cash from Financing 15.89
Net change in Cash 0.22
Free Cash Flow -13.10
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.34 14.00 1.67 247.83 23.12 40.44
BLISS GVS PHARMA LTD. 278.20 22.51 2.46 2943.05 117.20 293.15
CIPLA LTD 1431.55 28.35 3.35 115640.69 1165.55 1672.20
FERMENTA BIOTECH LIMITED 295.25 9.82 2.22 868.95 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.34 31.10 4.50 247.83 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 558.00 25.01 4.35 1613.21 490.00 789.95
ASTRAZENECA PHARMA IND LT 8488.45 102.01 26.55 21221.13 7630.00 10653.05
BLISS GVS PHARMA LTD. 278.20 29.91 2.54 2943.05 117.20 293.15

MONO PHARMACARE LIMITED shareholding pattern

Holding
Name Shares Category

News

Left Arrow
Right Arrow

MONO PHARMACARE LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
11.90 -4.79 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 12.80
  • 26 Days 12.50
  • 10 Days 12.70
  • 50 Days 13.00
  • 12 Days 12.70
  • 100 Days 15.20
  • 20 Days 12.50
  • 200 Days 20.00
12.50 PIVOT
First Support 12.50 First Resistance 12.50 Second Support 12.50 Second Resistance 12.50 Third Support 12.50 Third Resistance 12.50
RSI 50.01 ADX 32.83 MACD 0.20 Williams % R -60.42 Commodity Channel Index (CCI) 12.42
Date 2026-05-12 Week 2667.00 Same Day 2000.00 Month 16500.00
1 Year 0.53 3 Year 0.71
Over 1 Month
-1.57% down
Over 1 Year
-47.91% down
Over 3 Months
5.04% down
Over 3 Years
-25.67% down
Over 6 Months
-39.17% down
Over 5 Years
0.00% down

MONO PHARMACARE LIMITED Corporate Actions

Top Gainers

Top Losers

MONO PHARMACARE LIMITED Share Price

Parent organization
NSE symbol
Founded
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of [-]?

Answer Field

[-] share price is for NSE ₹ [-] & for BSE ₹ [-] as on May 18 2026 12:28 PM.

What is the Market Cap of [-] Share?

Answer Field

The market cap of [-] for NSE ₹ [-] & for BSE ₹ [-] as on May 18 2026 12:28 PM.

What is the 52 Week High and Low of [-]?

Answer Field

The 52 Week High and Low of [-] for NSE is ₹ [-] and ₹ [-] and for BSE is ₹ [-] and ₹ [-].

What is 1 year return for [-]?

Answer Field

The 1 year returns on the stock has been [-]%.

What is the P/E Ratio of [-] Share?

Answer Field

As on May 18 2026 12:28 PM the price-to-earnings (PE) ratio for [-] share is 7.14.

What is the PB ratio of [-] Share?

Answer Field

As on May 18 2026 12:28 PM, the price-to-book (PB) ratio for [-] share is 17.65.

How to Buy [-] Share on Bajaj Broking App?

Answer Field

To buy [-] shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “[-]”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|